THE ROLE OF BOARD MEMBERS

  • Board members are entrepreneurial executives with extensive experience in asset management, startups/SMEs and global corporations

  • Board controls investment, budget, nomination, compensation, audit, and guarantees alignment of interests

  • Board is regulated by an organization charter

  • Board operates its own internal processes and procedures based on EVCA professional standards

THE ROLE OF BOARD MEMBERS

  • Board members are entrepreneurial executives with extensive experience in asset management, startups/SMEs and global corporations

  • Board controls investment, budget, nomination, compensation, audit, and guarantees alignment of interests

  • Board is regulated by an organization charter

  • Board operates its own internal processes and procedures based on EVCA professional standards

remora.png
  • Home

  • Our Team

  • Primary Focus

  • Assets

  • News

  • Contact us

  • More

    • All Posts
    • REMORA
    • ACTIVEN
    • ATLAB
    • AVALUN
    • BEPATIENT
    • CYTUNE
    • FASTOX
    • IVO
    • OGD2
    Search
    Remora Capital
    • Nov 3, 2020
    • 2 min

    New Data Presented on the IL-15 superagonist SO-C101 at the Society for Immunotherapy of Cancer

    40
    Remora Capital
    • Jul 13, 2020
    • 2 min

    SOTIO Announces 1st Patient Dosed in Part B of Phase 1/1b Study with SO-C101 w/ Pembrolizumab

    510
    Remora Capital
    • Jun 21, 2020
    • 2 min

    SOTIO Presents New Data Showing Strong Anti-tumor Effect of IL-15 Superagonist SO-C101 in Mice

    00
    Remora Capital
    • Jul 11, 2019
    • 2 min

    SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101

    July 11, 2019 Source: Press Release SOTIO and Cytune Pharma, members of the PPF Group, announce today the first dosing of cancer patients...

    190
    Remora Capital
    • Aug 30, 2018
    • 3 min

    SOTIO and PPF complete acquisition of Cytune Pharma

    August 30, 2018 Source: Press Release, Prague SOTIO, a biotechnology company owned by the PPF Group, announces today the completion of th...

    150
    Remora Capital
    • Apr 10, 2018
    • 2 min

    SOTIO to Present Translational Data of the IL-15 Superagonist SO-C101 at 2018 AACR Annual Meeting

    April 10, 2018 Source: Press Release, Prague SOTIO, a biotechnology company owned by the PPF Group, announces today presentation of a pos...

    90
    Remora Capital
    • Jul 29, 2016
    • 3 min

    Cytune Pharma secures €6M in financing to advance lead immuno- oncology program to Phase I

    June 29, 2016 Source: Cytune Pharma’s Press Release Nantes, June 29, 2016 – Cytune Pharma SAS, a French biotechnology company focused on ...

    90
    Remora Capital
    • Feb 4, 2015
    • 3 min

    PPF Group acquires a minority stake in biotech company Cytune Pharma in cooperation w/ SOTIO

    February 4, 2015 Source: PPF Group N.V. - Press Release PPF Group has acquired a significant minority stake in Cytune Pharma SAS, a Frenc...

    50
    Legal Disclaimer
    • LinkedIn Social Icon